83_FR_56124 83 FR 55907 - Center for Scientific Review; Notice of Closed Meetings

83 FR 55907 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 217 (November 8, 2018)

Page Range55907-55907
FR Document2018-24466

Federal Register, Volume 83 Issue 217 (Thursday, November 8, 2018) 
[Federal Register Volume 83, Number 217 (Thursday, November 8, 2018)]
[Notices]
[Page 55907]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-24466]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Neurodevelopmental Disorders.
    Date: November 20, 2018.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Pat Manos, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301-408-
9866, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Review: Cancer Behavioral Research Communication in the 
New Media Environment.
    Date: November 30, 2018.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Weijia Ni, Ph.D., Chief/Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3100, MSC 7808, Bethesda, MD 
20892, 301-594-3292, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Virology.
    Date: December 4-5, 2018.
    Time: 8:30 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Susan Daum, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3202, Bethesda, MD 20892, 301-827-7233, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: AIDS and AIDS Related Research.
    Date: December 4, 2018.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Jingsheng Tuo, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5207, Bethesda, MD 20892, 301-451-8754, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Neurodegeneration.
    Date: December 4, 2018.
    Time: 10:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).

    Contact Person: Afia Sultana, Ph.D., Scientific Review Officer, 
National Institutes of Health, Center for Scientific Review, 6701 
Rockledge Drive, Room 4189, Bethesda, MD 20892, (301) 827-7083, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Toxicology and Pharmacology.
    Date: December 4, 2018.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place:National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Terez Shea-Donohue, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD 
20892, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: November 2, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-24466 Filed 11-7-18; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 217 / Thursday, November 8, 2018 / Notices 55907 airways compared to the blood, and the Dated: October 31, 2018. Agenda: To review and evaluate grant frequency of Mtb-specific CD153- Suzanne M. Frisbie, applications. expressing CD4 T cells inversely Deputy Director, Technology Transfer and Place: National Institutes of Health, 6701 correlates with bacterial loads in Intellectual Property Office, National Institute Rockledge Drive, Bethesda, MD 20892. granulomas. Further, in Mtb infected of Allergy and Infectious Diseases. Contact Person: Susan Daum, Ph.D., humans, CD153 defines a subset of [FR Doc. 2018–24469 Filed 11–7–18; 8:45 am] Scientific Review Officer, Center for Scientific Review, National Institutes of highly polyfunctional Mtb-specific CD4 BILLING CODE 4140–01–P Health, 6701 Rockledge Drive, Room 3202, T cells that are much more abundant in Bethesda, MD 20892, 301–827–7233, individuals with controlled latent Mtb susan.boyle-vavra@nih.gov. infection compared to those with active DEPARTMENT OF HEALTH AND HUMAN SERVICES Name of Committee: Center for Scientific TB. Since the expression of CD153 by Review Special Emphasis Panel; Member CD4 T cells is a major immune National Institutes of Health Conflict: AIDS and AIDS Related Research. mechanism of host protection against Date: December 4, 2018. Mtb infection, the discovery can be used Center for Scientific Review; Notice of Time: 10:00 a.m. to 5:00 p.m. to effectively diagnose and treat Mtb Closed Meetings Agenda: To review and evaluate grant infections in the future. applications. This technology is available for Pursuant to section 10(d) of the Place: National Institutes of Health, 6701 licensing for commercial development Federal Advisory Committee Act, as Rockledge Drive, Bethesda, MD 20892 in accordance with 35 U.S.C. 209 and 37 amended, notice is hereby given of the (Telephone Conference Call). CFR part 404, as well as for further following meetings. Contact Person: Jingsheng Tuo, Ph.D., development and evaluation under a The meetings will be closed to the Scientific Review Officer, Center for research collaboration. public in accordance with the Scientific Review, National Institutes of provisions set forth in sections Health, 6701 Rockledge Drive, Room 5207, Potential Commercial Applications: 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Bethesda, MD 20892, 301–451–8754, tuoj@ • Mycobacterium tuberculosis as amended. The grant applications and nei.nih.gov. diagnostic that measures the production the discussions could disclose Name of Committee: Center for Scientific of CD153 as an indicator of the disease confidential trade secrets or commercial Review Special Emphasis Panel; Member and its severity property such as patentable material, Conflict: Neurodegeneration. • A companion diagnostic can be and personal information concerning Date: December 4, 2018. used to determine the effectiveness of a individuals associated with the grant Time: 10:30 a.m. to 5:00 p.m. applications, the disclosure of which Agenda: To review and evaluate grant vaccine against a Mycobacterium would constitute a clearly unwarranted applications. tuberculosis infection in a subject Place: National Institutes of Health, 6701 invasion of personal privacy. • Therapeutic use to treat Rockledge Drive, Bethesda, MD 20892 Mycobacterium tuberculosis in a subject Name of Committee: Center for Scientific (Virtual Meeting). Review Special Emphasis Panel; Competitive Advantages: Neurodevelopmental Disorders. Contact Person: Afia Sultana, Ph.D., Date: November 20, 2018. Scientific Review Officer, National Institutes • Ability to be used as a target for Mtb of Health, Center for Scientific Review, 6701 Time: 12:00 p.m. to 5:00 p.m. diagnostics and therapeutics Agenda: To review and evaluate grant Rockledge Drive, Room 4189, Bethesda, MD Development Stage: applications. 20892, (301) 827–7083, sultanaa@ Place: National Institutes of Health, 6701 mail.nih.gov. • Proof of concept in animal models Rockledge Drive, Bethesda, MD 20892, Name of Committee: Center for Scientific and human subject. (Telephone Conference Call). Review Special Emphasis Panel; Member Inventors: Daniel L. Barber (NIAID), Contact Person: Pat Manos, Ph.D., Conflict: Toxicology and Pharmacology. Michelle A. Sallin (NIAID), Keith D. Scientific Review Officer, Center for Scientific Review, National Institutes of Date: December 4, 2018. Kauffman (NIAID) Time: 1:00 p.m. to 4:00 p.m. Health, 6701 Rockledge Drive, Room 5200, Publications: Sallin, Michelle A., et MSC 7846, Bethesda, MD 20892, 301–408– Agenda: To review and evaluate grant al. ‘‘Host resistance to pulmonary 9866, manospa@csr.nih.gov. applications. Mycobacterium tuberculosis infection Name of Committee: Center for Scientific Place:National Institutes of Health, 6701 requires CD153 expression.’’ Nature Review Special Emphasis Panel; PAR Rockledge Drive, Bethesda, MD 20892, microbiology (2018): 1. Review: Cancer Behavioral Research (Telephone Conference Call). Communication in the New Media Contact Person: Terez Shea-Donohue, Intellectual Property: HHS Reference Environment. Ph.D., Scientific Review Officer, Center for No. E–085–2018 US Patent Application Date: November 30, 2018. Scientific Review, National Institutes of No. 62/633,816 filed February 2, 2018 Time: 11:00 a.m. to 5:00 p.m. Health, 6701 Rockledge Drive, Room 2180, Licensing Contact: James M. Agenda: To review and evaluate grant MSC 7818, Bethesda, MD 20892, Robinson, 301–761–7542; applications. sheadonohuept@mail.nih.gov. Place: National Institutes of Health, 6701 (Catalogue of Federal Domestic Assistance James.Robinson4@nih.gov. Rockledge Drive, Bethesda, MD 20892 Program Nos. 93.306, Comparative Medicine; Collaborative Research Opportunity: (Virtual Meeting). 93.333, Clinical Research, 93.306, 93.333, The National Institute of Allergy and Contact Person: Weijia Ni, Ph.D., Chief/ 93.337, 93.393–93.396, 93.837–93.844, Infectious Diseases is seeking statements Scientific Review Officer, Center for Scientific Review, National Institutes of 93.846–93.878, 93.892, 93.893, National of capability or interest from parties Institutes of Health, HHS) daltland on DSKBBV9HB2PROD with NOTICES Health, 6701 Rockledge Drive, Room 3100, interested in collaborative research to MSC 7808, Bethesda, MD 20892, 301–594– Dated: November 2, 2018. further develop, evaluate or 3292, niw@csr.nih.gov. commercialize the methods of treating Sylvia L. Neal, Name of Committee: Center for Scientific human tuberculosis. For collaboration Program Analyst, Office of Federal Advisory Review Special Emphasis Panel; Member opportunities, please contact James M. Committee Policy. Conflict: Virology. Robison at 301–761–7542 or Date: December 4–5, 2018. [FR Doc. 2018–24466 Filed 11–7–18; 8:45 am] James.Robinson4@nih.gov. Time: 8:30 a.m. to 2:00 p.m. BILLING CODE 4140–01–P VerDate Sep<11>2014 16:51 Nov 07, 2018 Jkt 247001 PO 00000 Frm 00057 Fmt 4703 Sfmt 9990 E:\FR\FM\08NON1.SGM 08NON1


Document Created: 2018-11-08 06:23:13
Document Modified: 2018-11-08 06:23:13
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 20, 2018.
FR Citation83 FR 55907 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR